Biotech Values

[rkrw]

Dew, I don't think any of these projects is a piece of cake. We're probably talking a $30-50M investment with risk.

Definitely agree with you though, fragmin potentially could be reassessed if lovenox is approved. But mnta probably wont take it forward without a partner paying the bills. Either way, fragmin should be valued at zero.